These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictive value of geriatric oncology screening and geriatric assessment of older patients with cancer: A randomized clinical trial protocol (PROGNOSIS-RCT). Giger AW; Ditzel HM; Jørgensen TL; Ditzel HJ; Mohammadnejad A; Ewertz M; Pfeiffer P; Lund CM; Ryg J J Geriatr Oncol; 2022 Jan; 13(1):116-123. PubMed ID: 34362713 [TBL] [Abstract][Full Text] [Related]
3. GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial. van Soolingen NJ; Smorenburg CH; Hamaker ME; Groen WG; Retèl VP; Lok CAR; van de Poll-Franse LV; Trum JW Trials; 2020 Feb; 21(1):214. PubMed ID: 32087750 [TBL] [Abstract][Full Text] [Related]
4. Effect of comprehensive geriatric assessment for frail elderly patients operated for colorectal cancer-the colorectal cancer frailty study: study protocol for a randomized, controlled, multicentre trial. Normann M; Ekerstad N; Angenete E; Prytz M Trials; 2022 Nov; 23(1):948. PubMed ID: 36397083 [TBL] [Abstract][Full Text] [Related]
5. Protocol for a randomised controlled trial on impact of comprehensive geriatric and supportive assessment versus standard care in older adults with cancer undergoing curative treatment: The Geriatric Oncology SuPportive clinic for ELderly (GOSPEL) study. Goh WY; Neo HY; Teo HL; Koh MYH; Griva K; Lim MY; Ho FCH; Hum AYM J Geriatr Oncol; 2023 Jan; 14(1):101342. PubMed ID: 35843845 [TBL] [Abstract][Full Text] [Related]
6. Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept. Jiang R; Zhu J; Kim JW; Liu J; Kato K; Kim HS; Zhang Y; Zhang P; Zhu T; Aoki D; Yu A; Chen X; Wang X; Zhu D; Zhang W; Jia H; Shi T; Gao W; Yin S; Feng Y; Xiang L; Okamoto A; Zang R J Gynecol Oncol; 2020 Sep; 31(5):e86. PubMed ID: 32808504 [TBL] [Abstract][Full Text] [Related]
7. Effects of comprehensive geriatric assessment-guided interventions on physical performance and quality of life in older patients with advanced cancer: A randomized controlled trial (PROGNOSIS-RCT). Giger AW; Ditzel HM; Ditzel HJ; Ewertz M; Jørgensen TL; Pfeiffer P; Lund CM; Ryg J J Geriatr Oncol; 2024 Jan; 15(1):101658. PubMed ID: 37939628 [TBL] [Abstract][Full Text] [Related]
8. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial. Logan B; Viecelli AK; Johnson DW; Aquino EM; Bailey J; Comans TA; Gray LC; Hawley CM; Hickey LE; Janda M; Jaure A; Jose MD; Kalaw E; Kiriwandeniya C; Matsuyama M; Mihala G; Nguyen KH; Pascoe E; Pole JD; Polkinghorne KR; Pond D; Raj R; Reidlinger DM; Scholes-Robertson N; Varghese J; Wong G; Hubbard RE; Trials; 2023 May; 24(1):365. PubMed ID: 37254217 [TBL] [Abstract][Full Text] [Related]
9. Geriatric assessment and intervention in older vulnerable patients undergoing surgery for colorectal cancer: a protocol for a randomised controlled trial (GEPOC trial). Dolin TG; Mikkelsen M; Jakobsen HL; Nordentoft T; Pedersen TS; Vinther A; Zerahn B; Vistisen KK; Suetta C; Nielsen D; Johansen JS; Lund CM BMC Geriatr; 2021 Jan; 21(1):88. PubMed ID: 33516195 [TBL] [Abstract][Full Text] [Related]
10. A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study. Mahmoud AM; Biello F; Maggiora PM; Bruna R; Burrafato G; Cappelli M; Varughese F; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A BMC Geriatr; 2021 May; 21(1):320. PubMed ID: 34011271 [TBL] [Abstract][Full Text] [Related]
11. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals. Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer. Coleridge SL; Bryant A; Kehoe S; Morrison J Cochrane Database Syst Rev; 2021 Jul; 7(7):CD005343. PubMed ID: 34328210 [TBL] [Abstract][Full Text] [Related]
14. Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy. Zhang Y; Grant MS; Zhang X; Paraghamian SE; Tan X; Clark LH J Minim Invasive Gynecol; 2021 Jun; 28(6):1237-1243. PubMed ID: 33248314 [TBL] [Abstract][Full Text] [Related]
15. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. Fagotti A; Ferrandina G; Vizzielli G; Fanfani F; Gallotta V; Chiantera V; Costantini B; Margariti PA; Gueli Alletti S; Cosentino F; Tortorella L; Scambia G Eur J Cancer; 2016 May; 59():22-33. PubMed ID: 26998845 [TBL] [Abstract][Full Text] [Related]
16. Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer. Yokom DW; Alibhai SMH; Sattar S; Krzyzanowska MK; Puts MTE J Geriatr Oncol; 2018 Nov; 9(6):683-686. PubMed ID: 29540293 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer]. Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313 [No Abstract] [Full Text] [Related]
18. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
19. The effect of comprehensive assessment and multi-disciplinary management for the geriatric and frail patient: A multi-center, randomized, parallel controlled trial. Yao S; Zheng P; Ji L; Ma Z; Wang L; Qiao L; Wan Y; Sun N; Luo Y; Yang J; Wang H Medicine (Baltimore); 2020 Nov; 99(46):e22873. PubMed ID: 33181655 [TBL] [Abstract][Full Text] [Related]